TAC Cancer Research Results
TAC, total antioxidant capacity: Click to Expand ⟱
| Source: |
| Type: |
Total antioxidant capacity (TAC) refers to the ability of a biological sample (such as blood, tissues, or food) to counteract oxidative stress by neutralizing free radicals and reactive oxygen species (ROS).
May have reduced levels in cancers.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*Dose↝, *TAC↑, *SOD↑, *Albumin↑, *ROS↓, *other↑,
*hepatoP↑, *PKM2↓, *Hif1a↓, *MDA↓, *Catalase↓, *GSH↑, *SOD↑, *GPx↑, *TAC↑, *α-SMA↓, *Vim↓, *ROS↓,
*Imm↑, *Inflam↓, *Bacteria↓, *eff↑, *ROS↓, *MDA↓, *Catalase↑, *GSH↑, *TAC↑, *NF-kB↓, *NLRP3↓, *eff↑, *AST↓, *ALAT↓, *SOD↑, *GSTA1↑,
*NRF2↑, *NOX↓, *TAC↑, *ROS↓, *NQO1↑, *p‑PTEN↑, RUNX2↓, SOX9↓,
*antiOx↑, *hepatoP↑, *ROS↓, *lipid-P↓, *TAC↑, *NRF2↑, *HO-1↑, *NQO1↑, *PPARγ↑, *Inflam↓, *Apoptosis↓, *Bcl-2↑, *BAX↓, *Cyt‑c↓, *Casp3↓,
*ALAT↓, *AST↓, *MDA↓, *SOD↑, *GSH↑, *TAC↑, *eff↑, *TGF-β1↓, *SMAD3↓, *MMP9↑, *NRF2↑, *antiOx↑, *hepatoP↑, *Inflam↓, *NF-kB↓, *NO↓, *cAMP↑, *ROS↓,
*Dose↝, *TAC↑, *MDA↓, *RenoP↑, *PI3K↓, *Akt↓, *ROS↓, *Inflam↓, PPARγ↝, *NF-kB↓, *IL6↓, *TNF-α↓, *iNOS↓, *ALAT↓, *AST↓, *Urea↓, *Catalase↑, *SOD↑, *GPx↑, *GSH↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *BioAv↝, *Half-Life↑, *BioAv↓, *BioAv↑, *cardioP↑, *neuroP↑, *H2O2↓, *VitC↑, *VitE↑, *GPx↑, *GSH↑, *MPO↓, *GSTs↓, *SOD↑, *NF-kB↓, *IL1β↓, *IL6↓, *IL10↑, *MAPK↓, *Akt↓, *COX2↓, *TNF-α↓, *TGF-β1↑, *NO↓, *GSR↑, *NRF2↑, *HO-1↑, *TAC↑, *Inflam↓, *BBB↑, *neuroP↑, *memory↑,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
*antiOx↑, *Thiols↑, *GSH↑, *TAC↑, *SOD↑, *GPx↑, *Catalase↑, *ALP↓, *ALAT↓, *AST↓, *creat↓, *BUN↓, *H2O2↓, *MDA↓, *ROS↓, cardioP↑, hepatoP↑, neuroP↑,
*TAC↑, *CRP↓, *AST↓, *ALAT↓, *toxicity↓, *GSH↑, *SOD↑, *Catalase↑, *hepatoP↑,
*NO↓, *MDA↓, *TAC↑, *Hif1a↓, *iNOS↓,
*RenoP↑, *ROS↓, *SIRT1↓, *NRF2↑, *HO-1↑, *GSH↑, *TAC↑, *SOD↑, *MDA↓, *NO↓, *iNOS↓, *NHE3↑, *PI3K↑,
| - |
in-vitro, |
Nor, |
THP1 |
|
|
|
- |
in-vitro, |
Nor, |
RAW264.7 |
|
|
|
*ROS↓, *MAPK↓, *NF-kB↓, *TAC↑, *NRF2↑, *Akt↑, *AMPK↑, *Inflam↓,
*antiOx↑, *TOS↑, *TAC↑, *neuroP↑,
*RenoP↑, *TAC↑, *ROS↓, *lipid-P↓, *p38↓, *MAPK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *MDA↓, *GPx↑, *GSR↑, *Catalase↑, *BUN↓, *LDH↓, *IL1β↓,
Showing Research Papers: 1 to 16 of 16
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 16
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
PPARγ↝, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
SOX9↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
RUNX2↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, hepatoP↑, 1, neuroP↑, 1, Risk↓, 1,
Total Targets: 7
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 5, Catalase↓, 1, Catalase↑, 5, GPx↑, 5, GSH↑, 8, GSR↑, 2, GSTA1↑, 1, GSTs↓, 1, H2O2↓, 2, HO-1↑, 4, lipid-P↓, 2, MDA↓, 8, MPO↓, 1, NQO1↑, 3, NRF2↑, 8, ROS↓, 13, SOD↑, 9, SOD2↑, 1, TAC↑, 16, Thiols↑, 1, TOS↑, 1, TrxR1↑, 1, VitC↑, 1, VitE↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 6, AMPK↑, 2, BUN↓, 2, cAMP↑, 1, CRM↑, 1, LDH↓, 1, LDL↓, 1, PKM2↓, 1, PPARγ↑, 1, SIRT1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, Akt↑, 1, Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, Casp3↓, 1, Cyt‑c↓, 1, iNOS↓, 3, MAPK↓, 3, p38↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↑, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
NQO2↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, PI3K↑, 1, p‑PTEN↑, 1,
Migration(tgid=13) ⓘ
MMP9↑, 1, SMAD3↓, 1, TGF-β1↓, 1, TGF-β1↑, 1, Vim↓, 1, α-SMA↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 2, NO↓, 4,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, NHE3↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, CRP↓, 1, IL10↑, 1, IL1β↓, 2, IL6↓, 2, Imm↑, 1, Inflam↓, 7, NF-kB↓, 6, TNF-α↓, 2,
Cellular Microenvironment(tgid=17) ⓘ
NOX↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, BioAv↝, 1, Dose↝, 2, eff↑, 3, Half-Life↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 6, Albumin↑, 1, ALP↓, 1, AST↓, 5, creat↓, 1, CRP↓, 1, IL6↓, 2, LDH↓, 1, Urea↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, AntiDiabetic↑, 1, cardioP↑, 2, hepatoP↑, 4, memory↑, 1, neuroP↑, 3, RenoP↑, 3, Strength↑, 1, toxicity↓, 1, toxicity⇅, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 96
Scientific Paper Hit Count for: TAC, total antioxidant capacity
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:626 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page